[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100363473":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":17,"responsibleParty":37,"collaborators":7,"id":41,"slug":42,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":45,"acronym":7,"eligibilityCriteria":46,"healthyVolunteers":43,"sex":47,"minAge":48,"maxAge":7,"enrollmentInfo":49,"targetDuration":7,"studyType":52,"phases":7,"briefSummary":53,"conditions":54,"keywords":7,"overallStatus":19,"whyStopped":7,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":65},{"fullName":5,"class":6},"First Affiliated Hospital of Fujian Medical University","OTHER",null,[9,14],{"name":10,"role":11,"phone":12,"phoneExt":12,"email":13},"Ning Wang, MD, PhD","CONTACT","13805015340","ningwang@fjmu.edu.cn",{"name":15,"role":11,"phone":7,"phoneExt":7,"email":16},"Ming Jin, MD","Safariday@live.com",[18],{"facility":5,"status":19,"city":20,"state":7,"zip":7,"country":21,"countryCode":22,"cosmosGeoPoint":23,"geoPoint":28,"contacts":29},"RECRUITING","Fuzhou","China","CN",{"type":24,"coordinates":25},"Point",[26,27],119.30611,26.06139,{"lat":27,"lon":26},[30,31,34],{"name":15,"role":11,"phone":7,"phoneExt":7,"email":16},{"name":32,"role":33,"phone":7,"phoneExt":7,"email":7},"Ning Wang, MD,PhD","PRINCIPAL_INVESTIGATOR",{"name":35,"role":36,"phone":7,"phoneExt":7,"email":7},"Wan-Jin Chen, MD,PhD","SUB_INVESTIGATOR",{"type":38,"investigatorFullName":39,"investigatorTitle":40,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"SPONSOR_INVESTIGATOR","Ning Wang, MD., PhD.","Professor","100363473","a-registered-cohort-study-on-duchenne-muscular-dystrophy-100363473",false,"NCT04012671","A Registered Cohort Study on Duchenne Muscular Dystrophy","Inclusion Criteria:\n\n* Beyond 2 years old\n* Diagnosis with Duchenne Muscular Dystrophy, and female carriers, genotypically confirmed\n* Diagnosis should be supported by muscle biopsy, if no genetic confirmation.\n\nExclusion Criteria:\n\n* Presence of other clinically significant illness","ALL","2 Years",{"count":50,"type":51},2000,"ESTIMATED","OBSERVATIONAL","Dystrophinopathy is a term of X-linked recessive genetic disease, including Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and the X-linked dilated cardiomyopathy. The aim of this study is to determine the clinical spectrum and natural progression of dystrophinopathy in a prospective multicenter natural history study, to assess the clinical, genetic of patients with dystrophinopathy to optimize clinical management.",[55],"Duchenne Muscular Dystrophy","2021-03-18",{"date":58,"type":59},"2021-03-22","ACTUAL",{"date":61,"type":59},"2019-07-01",{"date":63,"type":51},"2049-12-31",{"name":39,"class":6},1]